Clinical Characteristics of Patients With COVID-19 Receiving Emergency Medical Services | Emergency Medicine | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Clinical Characteristics of Patients With Coronavirus Disease 2019 (COVID-19) Receiving Emergency Medical Services in King County, Washington

Educational Objective
To understand the clinical characteristics of patients with COIVD-19 receiving emergency medical services
1 Credit CME
Key Points

Question  What is the clinical presentation to emergency medical services among persons with coronavirus disease 2019 (COVID-19)?

Findings  This cohort study of 124 patients with COVID-19 revealed that most patients with COVID-19 presenting to emergency medical services were older and had multiple chronic health conditions. Initial concern, symptoms, and examination findings were heterogeneous and not consistently characterized as febrile respiratory illness.

Meaning  The findings of this study suggest that the conventional description of febrile respiratory illness may not adequately identify COVID-19 in the prehospital emergency setting.

Abstract

Importance  The ability to identify patients with coronavirus disease 2019 (COVID-19) in the prehospital emergency setting could inform strategies for infection control and use of personal protective equipment. However, little is known about the presentation of patients with COVID-19 requiring emergency care, particularly those who used 911 emergency medical services (EMS).

Objective  To describe patient characteristics and prehospital presentation of patients with COVID-19 cared for by EMS.

Design, Setting, and Participants  This retrospective cohort study included 124 patients who required 911 EMS care for COVID-19 in King County, Washington, a large metropolitan region covering 2300 square miles with 2.2 million residents in urban, suburban, and rural areas, between February 1, 2020, and March 18, 2020.

Exposures  COVID-19 was diagnosed by reverse transcription–polymerase chain reaction detection of severe acute respiratory syndrome coronavirus 2 from nasopharyngeal swabs. Test results were available a median (interquartile range) of 5 (3-9) days after the EMS encounter.

Main Outcomes and Measures  Prevalence of clinical characteristics, symptoms, examination signs, and EMS impression and care.

Results  Of the 775 confirmed COVID-19 cases in King County, EMS responded to 124 (16.0%), with a total of 147 unique 911 encounters. The mean (SD) age was 75.7 (13.2) years, 66 patients (53.2%) were women, 47 patients (37.9%) had 3 or more chronic health conditions, and 57 patients (46.0%) resided in a long-term care facility. Based on EMS evaluation, 43 of 147 encounters (29.3%) had no symptoms of fever, cough, or shortness of breath. Based on individual examination findings, fever, tachypnea, or hypoxia were only present in a limited portion of cases, as follows: 43 of 84 encounters (51.2%), 42 of 131 (32.1%), and 60 of 112 (53.6%), respectively. Advanced care was typically not required, although in 24 encounters (16.3%), patients received care associated with aerosol-generating procedures. As of June 1, 2020, mortality among the study cohort was 52.4% (65 patients).

Conclusions and Relevance  The findings of this cohort study suggest that screening based on conventional COVID-19 symptoms or corresponding examination findings of febrile respiratory illness may not possess the necessary sensitivity for early diagnostic suspicion, at least in the prehospital emergency setting. The findings have potential implications for early identification of COVID-19 and effective strategies to mitigate infectious risk during emergency care.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Article Information

Accepted for Publication: June 4, 2020.

Published: July 8, 2020. doi:10.1001/jamanetworkopen.2020.14549

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Yang BY et al. JAMA Network Open.

Corresponding Author: Thomas Rea, MD, MPH, Department of Medicine, University of Washington, 401 Fifth Avenue, Suite 1200, Seattle, WA 98104 (rea123@uw.edu).

Author Contributions: Ms Barnard and Dr Rea had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Yang, Barnard, Drucker, Counts, Murphy, Sayre, Rea.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Yang, Barnard, Rodriquez, Jacinto, May, Rea.

Critical revision of the manuscript for important intellectual content: Emert, Drucker, Schwarcz, Counts, Murphy, Guan, Kume, Sayre, Rea.

Statistical analysis: Barnard, Emert, Drucker, Counts, May.

Obtained funding: Jacinto.

Administrative, technical, or material support: Yang, Emert, Drucker, Schwarcz, Counts, Murphy, Guan, Kume, Rodriquez, Jacinto, Rea.

Supervision: Yang, Emert, Jacinto, Sayre, Rea.

Conflict of Interest Disclosures: Dr Sayre reported receiving support from Stryker to support fellowship medical education outside the submitted work. No other disclosures were reported.

Additional Contributions: We wish to acknowledge Public Health–Seattle and King County, the Washington State Department of Health, the US Centers for Disease Control and Prevention, and the telecommunicators and emergency medical service professionals of Seattle and greater King County.

References
1.
Zhu  N , Zhang  D , Wang  W ,  et al; China Novel Coronavirus Investigating and Research Team.  A novel coronavirus from patients with pneumonia in China, 2019.   N Engl J Med. 2020;382(8):727-733. doi:10.1056/NEJMoa2001017PubMedGoogle ScholarCrossref
2.
Rothe  C , Schunk  M , Sothmann  P ,  et al.  Transmission of 2019-nCoV infection from an asymptomatic contact in Germany.   N Engl J Med. 2020;382(10):970-971. doi:10.1056/NEJMc2001468PubMedGoogle ScholarCrossref
3.
Holshue  ML , DeBolt  C , Lindquist  S ,  et al; Washington State 2019-nCoV Case Investigation Team.  First case of 2019 novel coronavirus in the United States.   N Engl J Med. 2020;382(10):929-936. doi:10.1056/NEJMoa2001191PubMedGoogle ScholarCrossref
4.
Arentz  M , Yim  E , Klaff  L ,  et al.  Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state.   JAMA. 2020;323(16):1612-1614. doi:10.1001/jama.2020.4326PubMedGoogle ScholarCrossref
5.
Onder  G , Rezza  G , Brusaferro  S .  Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy.   JAMA. 2020;323(18):1775-1776. doi:10.1001/jama.2020.4683PubMedGoogle Scholar
6.
Wu  Z , McGoogan  JM .  Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention.   JAMA. 2020;323(13):1239-1242. doi:10.1001/jama.2020.2648PubMedGoogle ScholarCrossref
7.
Wang  D , Hu  B , Hu  C ,  et al.  Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.   JAMA. 2020;323(11):1061-1069. doi:10.1001/jama.2020.1585PubMedGoogle ScholarCrossref
8.
Guan  WJ , Ni  ZY , Hu  Y ,  et al; China Medical Treatment Expert Group for Covid-19.  Clinical characteristics of coronavirus disease 2019 in China.   N Engl J Med. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032PubMedGoogle ScholarCrossref
9.
Huang  C , Wang  Y , Li  X ,  et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.   Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5PubMedGoogle ScholarCrossref
10.
von Elm  E , Altman  DG , Egger  M , Pocock  SJ , Gøtzsche  PC , Vandenbroucke  JP ; STROBE Initiative.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.   Lancet. 2007;370(9596):1453-1457.PubMedGoogle ScholarCrossref
11.
McMichael  TM , Currie  DW , Clark  S ,  et al; Public Health–Seattle and King County, EvergreenHealth, and CDC COVID-19 Investigation Team.  Epidemiology of COVID-19 in a long-term care facility in King County, Washington.   N Engl J Med. 2020;382(21):2005-2011. doi:10.1056/NEJMoa2005412PubMedGoogle ScholarCrossref
12.
Tran  K , Cimon  K , Severn  M , Pessoa-Silva  CL , Conly  J .  Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review.   PLoS One. 2012;7(4):e35797. doi:10.1371/journal.pone.0035797PubMedGoogle Scholar
13.
van Doremalen  N , Bushmaker  T , Morris  DH ,  et al.  Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1.   N Engl J Med. 2020;382(16):1564-1567.PubMedGoogle ScholarCrossref
14.
Judson  SD , Munster  VJ .  Nosocomial transmission of emerging viruses via aerosol-generating medical procedures.   Viruses. 2019;11(10):E940. doi:10.3390/v11100940PubMedGoogle Scholar
15.
Cha AE. When COVID-19 claimed two of their own, these EMTs grieved and kept on going. The Washington Post. Published April 20, 2020. Accessed May 30, 2020. https://www.washingtonpost.com/health/when-covid-19-claimed-two-of-their-own-these-emts-grieved-and-carried-on/2020/04/20/200c9542-81c5-11ea-a3ee-13e1ae0a3571_story.html
16.
Murphy  DL , Barnard  LM , Drucker  DJ ,  et al. Occupational exposures and programmatic response to COVID-19 pandemic: an emergency medical services experience. medRxiv. Preprint posted May 24, 2020. doi:10.1101/2020.05.22.20110718
17.
Foster  A , Florea  V , Fahrenbruch  C , Blackwood  J , Rea  TD .  Availability and accuracy of EMS information about chronic health and medications in cardiac arrest.   West J Emerg Med. 2017;18(5):864-869. doi:10.5811/westjem.2017.5.33198PubMedGoogle ScholarCrossref
18.
Dumas  F , Blackwood  J , White  L ,  et al.  The relationship between chronic health conditions and outcome following out-of-hospital ventricular fibrillation cardiac arrest.   Resuscitation. 2017;120:71-76. doi:10.1016/j.resuscitation.2017.08.239PubMedGoogle ScholarCrossref
19.
US Centers for Disease Control and Prevention. Overview of testing for SARS-CoV-2. Updated May 3, 2020. Accessed June 15, 2020. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close